News
Leadership Transition at NATROX® Wound Care
Inotec AMD, the leading innovator in Continuous Topical Oxygen Therapy (cTOT) for advanced wound care and parent company of NATROX Wound Care, announces a leadership transition. After seven years of dedicated service, Craig Kennedy has accepted another role in the industry and will be stepping down as CEO. With this transition, Gordie Nye will assume the role of CEO while continuing as Chairman of the Inotec AMD Board.
Read MoreVA Grants 5-year Extension to FSS Contract for NATROX® O₂ Continuous Topical Oxygen Therapy (cTOT)
January 30, 2025
As part of LER Magazine’s (Lower Extremity Review) 15th anniversary celebration, they asked readers to weigh in on the many facets of innovation that have helped improve patient outcomes in lower extremity care.
January 07, 2025